Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
This preliminary study supports further investigation of divalproex in the treatment of alcohol withdrawal.
2
By random assignment, subjects received either divalproex sodium or placebo in conjunction with lithium.
3
After cessation of chemotherapy and administration of olanzapine and divalproex sodium, symptoms were subsided within 10 days.
4
The present study represents an open-label clinical trial comparing treatment with a benzodiazepine (lorazepam) to divalproex in 11 inpatients with uncomplicated alcohol withdrawal syndrome.